RT Journal Article
SR Electronic
T1 Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy
JF Archives of Disease in Childhood
JO Arch Dis Child
FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
SP 57
OP 59
DO 10.1136/adc.2003.048504
VO 90
IS 1
A1 M Tan
A1 R Appleton
YR 2005
UL http://adc.bmj.com/content/90/1/57.abstract
AB Attention deficit hyperactivity disorder (ADHD) is characterised by inattention, impulsivity, and hyperactivity. The DSM-IV diagnosis of ADHD requires the presence of six of nine items or features that must have been present for at least six months, to have had an onset before 7 years of age, and to have resulted in significant distress or impairment.1 In the general population, the prevalence of ADHD is approximately 5%.2 There is a high co-morbidity of epilepsy and attentional and behavioural problems,3,4 including ADHD, and it has been estimated that at least 20% of patients with epilepsy may present with features of ADHD.5